Enedra Therapeutics

Drug discovery

Enedra is harnessing the power of synthetic lethality and advanced computational Systems Biology to create therapeutics that work against the complexity, biological and mutational heterogeneity of cancer.

Focus: Drug discovery platform 

Team: Andreas Ballis and Alex Gutteridge

Website: https://enedratx.com/


Be part of SBC Catalyser Programme!

Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.